Related Experiment Video
Updated: May 6, 2026
08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
5.5K
Colonization and infection due to multi-resistant bacteria in neonates: a single center analysis
R Haase1, D Worlitzsch2, F Schmidt1
1Department of Pediatrics, University Hospital, Halle (Saale), Germany.
Klinische Padiatrie
|October 30, 2013
Summary
Multi-resistant pathogens (MRPs) increased in neonates, with Gram-negative MRPs showing a rise. Early detection through microbiological screening aids in preventing nosocomial infections and managing neonatal sepsis.
Area of Science:
- Neonatalogy
- Infectious Diseases
- Microbiology
Background:
- Increasing prevalence of multi-resistant pathogens (MRPs) poses a significant threat to neonatal health.
- Systemic infections in neonates contribute substantially to morbidity and mortality.
Purpose of the Study:
- To analyze clinical risk factors and incidence of systemic infections in neonates colonized with MRPs.
- To investigate the trend of MRP prevalence and associated infections in a neonatal intensive care unit.
Main Methods:
- Retrospective analysis of neonates admitted between January 2011 and December 2012.
- Definition of MRPs including Vancomycin-resistant Enterococci, Methicillin-resistant Staphylococcus aureus, and resistant Gram-negative bacilli.
- Comparison of clinical risk factors and infection rates between MRP-positive and MRP-negative neonates.
Main Results:
- Out of 635 neonates, 31 were positive for MRPs, with 2 developing MRP-associated infections, both discharged without long-term issues.
- Low gestational age and mechanical ventilation were identified as risk factors for MRP colonization.
- Incidence density of Gram-negative MRPs increased significantly from 2011 to 2012, while the overall sepsis rate remained stable.
Conclusions:
- The prevalence of Gram-negative MRPs in neonates has increased, highlighting the need for vigilance.
- Microbiological screening is effective for early detection of MRP colonization, aiding in the prevention of nosocomial infections.
- Continued efforts are crucial for the prevention and early treatment of sepsis, including that caused by non-resistant bacteria.
Related Concept Videos
01:28Development of the Oral Microbiota
75
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
75
01:30Development of Human Microbiota
73
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
73
01:25Clinical Significance of Antibiotic Resistance
115
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
115
01:20Infection
11.8K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.8K
01:26Factors Affecting the Risk of Infection
14.1K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.1K
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
5.8K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
5.8K